LncRNA SNHG14 promotes non-small cell lung cancer progression by sponging miR-382-5p

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. 2018. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68:394–424. doi: https://doi.org/10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• Castro-Oropeza R, Melendez-Zajgla J, Maldonado V, Vazquez-Santillan K. 2018. The emerging role of lncRNAs in the regulation of cancer stem cells. Cell Oncol. 41:585–603. doi: https://doi.org/10.1007/s13402-018-0406-4
   PubMed Web of Science ®Google Scholar
• Chen DL, Ju HQ, Lu YX, Chen LZ, Zeng ZL, Zhang D-s, Luo H-y, Wang F, Qiu M-z, Wang D-s, et al. 2016. Long non-coding RNA XIST regulates gastric cancer progression by acting as a molecular sponge of miR-101 to modulate EZH2 expression. J Exp Clin Cancer Res. 35:142. doi: https://doi.org/10.1186/s13046-016-0420-1
   PubMed Web of Science ®Google Scholar
• Chen T, Ren H, Thakur A, Yang T, Li Y, Zhang S, Wang T, Chen M. 2017. miR-382 inhibits tumor progression by targeting SETD8 in non-small cell lung cancer. Biomed Pharmacother. 86:248–253. doi: https://doi.org/10.1016/j.biopha.2016.12.007
   PubMed Web of Science ®Google Scholar
• Chen D, Zhang Y, Lin Y, Shen F, Zhang Z, Zhou J. 2019. MicroRNA-382 inhibits cancer cell growth and metastasis in NSCLC via targeting LMO3. Exp Ther Med. 17:2417–2424.
   Web of Science ®Google Scholar
• Clinical Lung Cancer Genome P, Network Genomic M. 2013. A genomics-based classification of human lung tumors. Sci Transl Med. 5:209ra153.
   PubMed Web of Science ®Google Scholar
• Diederichs S, Haber DA. 2007. Dual role for argonautes in microRNA processing and posttranscriptional regulation of microRNA expression. Cell. 131:1097–1108. doi: https://doi.org/10.1016/j.cell.2007.10.032
   PubMed Web of Science ®Google Scholar
• Dong H, Wang W, Mo S, Liu Q, Chen X, Chen R, Zhang Y, Zou K, Ye M, He X. 2018. Long non-coding RNA SNHG14 induces trastuzumab resistance of breast cancer via regulating PABPC1 expression through H3K27 acetylation. J Cell Mol Med. 22:4935–4947. doi: https://doi.org/10.1111/jcmm.13758
   PubMed Web of Science ®Google Scholar
• Ebert MS, Neilson JR, Sharp PA. 2007. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat Methods. 4:721–726. doi: https://doi.org/10.1038/nmeth1079
   PubMed Web of Science ®Google Scholar
• Fang Y, Fang D, Hu J. 2012. MicroRNA and its roles in esophageal cancer. Med Sci Monit. 18:RA22–RA30.
   Web of Science ®Google Scholar
• Feng J, Qi B, Guo L, Chen LY, Wei XF, Wei X-F, Liu Y-Z, Zhao B-S. 2017. miR-382 functions as a tumor suppressor against esophageal squamous cell carcinoma. World J Gastroenterol. 23:4243–4251. doi: https://doi.org/10.3748/wjg.v23.i23.4243
   Google Scholar
• Gu J, Wang Y, Wu X. 2013. MicroRNA in the pathogenesis and prognosis of esophageal cancer. Curr Pharm Des. 19:1292–1300. doi: https://doi.org/10.2174/1381612811319350009
   PubMed Web of Science ®Google Scholar
• Jiao P, Hou J, Yao M, Wu J, Ren G. 2019. SNHG14 silencing suppresses the progression and promotes cisplatin sensitivity in non-small cell lung cancer. Biomed Pharmacother. 117:109164. doi: https://doi.org/10.1016/j.biopha.2019.109164
   PubMed Web of Science ®Google Scholar
• Klein CA. 2009. Parallel progression of primary tumours and metastases. Nat Rev Cancer. 9:302–312. doi: https://doi.org/10.1038/nrc2627
   PubMed Web of Science ®Google Scholar
• Liu Y, Wang Y, Fu X, Lu Z. 2018a. Long non-coding RNA NEAT1 promoted ovarian cancer cells’ metastasis through regulation of miR-382-3p/ROCK1 axial. Cancer Sci. 109:2188–2198. doi: https://doi.org/10.1111/cas.13647
   PubMed Web of Science ®Google Scholar
• Liu Z, Yan Y, Cao S, Chen Y. 2018b. Long non-coding RNA SNHG14 contributes to gastric cancer development through targeting miR-145/SOX9 axis. J Cell Biochem. 119:6905–6913. doi: https://doi.org/10.1002/jcb.26889
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. doi: https://doi.org/10.1006/meth.2001.1262
   PubMed Web of Science ®Google Scholar
• Matboli M, Shafei AE, Ali MA, El-Din Ahmed TS, Naser M, Abdel-Rahman T, Anber N, Ali M. 2019. Role of extracellular LncRNA-SNHG14/miRNA-3940-5p/NAP12 mRNA in colorectal cancer. Arch Physiol Biochem. 1–7. doi: https://doi.org/10.1080/13813455.2019.1650070
   Web of Science ®Google Scholar
• Mercer TR, Dinger ME, Mattick JS. 2009. Long non-coding RNAs: insights into functions. Nat Rev Genet. 10:155–159. doi: https://doi.org/10.1038/nrg2521
   PubMed Web of Science ®Google Scholar
• Ren Y, Zhang H, Jiang P. 2018. MicroRNA-382 inhibits cell growth and migration in colorectal cancer by targeting SP1. Biol Res. 51:51. doi: https://doi.org/10.1186/s40659-018-0200-9
   PubMed Web of Science ®Google Scholar
• Takawa M, Cho HS, Hayami S, Toyokawa G, Kogure M, Yamane Y, Iwai Y, Maejima K, Ueda K, Masuda A, et al. 2012. Histone lysine methyltransferase SETD8 promotes carcinogenesis by deregulating PCNA expression. Cancer Res. 72:3217–3227. doi: https://doi.org/10.1158/0008-5472.CAN-11-3701
   PubMedGoogle Scholar
• Tan H, He Q, Gong G, Wang Y, Li J, Wang J, Zhu D, Wu X. 2016. miR-382 inhibits migration and invasion by targeting ROR1 through regulating EMT in ovarian cancer. Int J Oncol. 48:181–190. doi: https://doi.org/10.3892/ijo.2015.3241
   PubMed Web of Science ®Google Scholar
• Veschi V, Liu Z, Voss TC, Ozbun L, Gryder B, Yan C, Hu Y, Ma A, Jin J, Mazur SJ. 2017. Epigenetic siRNA and chemical screens identify SETD8 inhibition as a therapeutic strategy for p53 activation in high-Risk neuroblastoma. Cancer Cell. 31:50–63. doi: https://doi.org/10.1016/j.ccell.2016.12.002
   Google Scholar
• Wang Q, Teng Y, Wang R, Deng D, You Y, Peng Y, Shao N, Zhi F. 2018. The long non-coding RNA SNHG14 inhibits cell proliferation and invasion and promotes apoptosis by sponging miR-92a-3p in glioma. Oncotarget. 9:12112–12124. doi: https://doi.org/10.18632/oncotarget.23960
   PubMedGoogle Scholar
• Wu K, Li J, Qi Y, Zhang C, Zhu D, Liu D, Zhao S. 2019. SNHG14 confers gefitinib resistance in non-small cell lung cancer by up-regulating ABCB1 via sponging miR-206-3p. Biomed Pharmacother. 116:108995. doi: https://doi.org/10.1016/j.biopha.2019.108995
   PubMed Web of Science ®Google Scholar
• Yang L, Lin C, Jin C, Yang JC, Tanasa B, Li W, Merkurjev D, Ohgi KA, Meng D, Zhang J, et al. 2013. lncRNA-dependent mechanisms of androgen-receptor-regulated gene activation programs. Nature. 500:598–602. doi: https://doi.org/10.1038/nature12451
   PubMed Web of Science ®Google Scholar
• Yao H, Xia D, Li ZL, Ren L, Wang MM, et al. 2019. MiR-382 functions as tumor suppressor and chemosensitizer in colorectal cancer. Biosci Rep. 39.
   Web of Science ®Google Scholar
• Ye T, Zhang N, Wu W, Yang B, Wang J, Huang W, Tang D. 2019. SNHG14 promotes the tumorigenesis and metastasis of colorectal cancer through miR-32-5p/SKIL axis. In Vitro Cell Dev Biol Anim. 55:812–820. doi: https://doi.org/10.1007/s11626-019-00398-5
   PubMed Web of Science ®Google Scholar
• Zhang W, Duan W, Mo Z, Wang J, Yang W, Wu W, Li X, Lin S, Tan Y, Wei W. 2020. Upregulation of SNHG14 suppresses cell proliferation and metastasis of colorectal cancer by targeting miR-92b-3p. J Cell Biochem. 121:1998–2008. doi: https://doi.org/10.1002/jcb.29434
   PubMedGoogle Scholar
• Zhang Z, Wang Y, Zhang W, Li J, Liu W, Lu W. 2019. Long non-coding RNA SNHG14 exerts oncogenic functions in non-small cell lung cancer through acting as an miR-340 sponge. Biosci Rep. 39:BSR20180941. doi: https://doi.org/10.1042/BSR20180941
   PubMedGoogle Scholar
• Zhao L, Sun H, Kong H, Chen Z, Chen B, Zhou M. 2017. The lncrna-TUG1/EZH2 axis promotes pancreatic cancer cell proliferation, migration and EMT phenotype formation through sponging mir-382. Cell Physiol Biochem. 42:2145–2158. doi: https://doi.org/10.1159/000479990
   PubMedGoogle Scholar
• Zhou B, Song J, Han T, Huang M, Jiang H, Qiao H, Shi J, Wang Y. 2016. MiR-382 inhibits cell growth and invasion by targeting NR2F2 in colorectal cancer. Mol Carcinog. 55:2260–2267. doi: https://doi.org/10.1002/mc.22466
   PubMed Web of Science ®Google Scholar